An analysis of ongoing trials suggests that mRNA cancer vaccines have the potential to deliver health benefits worth $75 ...

A Stanford-led study probes why a very small number of people develop heart inflammation shortly after mRNA COVID-19 ...

I was taken aback to hear the government had selected GC Biopharma as a company to support in phase 1 (first-stage clinical ...

Stanford scientists have uncovered how mRNA COVID-19 vaccines can very rarely trigger heart inflammation in young men — and ...

Moderna announced Thursday it will receive up to $54.3 million from a global vaccine partnership to fund its ongoing research ...

Since the announcements by federal health authorities earlier this year that federal mRNA vaccine funding will be curtailed, ...

RNA vaccines, such as those used against COVID-19, are effective at generating antibody responses. These antibodies are ...

A team led by Rensselaer Polytechnic Institute (RPI) professors Georges Belfort, Ph.D. (PI), and Pankaj Karande, Ph.D. (co-PI ...

As the immune system weakens with age, scientists have found a way to restore some of its lost strength. By delivering mRNA ...

Moderna (MRNA) is back in the spotlight after securing up to $54.3 million from CEPI to help fund a Phase 3 trial of its H5 bird flu vaccine candidate, mRNA-1018. See our latest analysis for Moderna.

Can the weakened immune systems of older individuals be rejuvenated? Researchers from the German Cancer Research Center (DKFZ ...